» Articles » PMID: 28246514

Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices

Overview
Journal Korean J Radiol
Specialty Radiology
Date 2017 Mar 2
PMID 28246514
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term outcomes from these procedures based on our institutional experience.

Materials And Methods: We conducted a retrospective review of patients with isolated gastric varices who underwent either TIPS with a covered stent or BRTO between January 2000 and July 2013. We identified 52 consecutive patients, 27 who had received TIPS with a covered stent and 25 who had received BRTO. We compared procedural complications, re-bleeding rates, and clinical outcomes between the two groups.

Results: There were no significant differences in procedural complications between patients who underwent TIPS (7%) and those who underwent BRTO (12%) ( = 0.57). There were also no statistically significant differences in re-bleeding rates from gastric varices between the two groups (TIPS, 7% [2/27]; BRTO, 8% [2/25]; = 0.94) or in developing new ascites following either procedure (TIPS, 4%; BRTO, 4%; = 0.96); significantly more patients who underwent TIPS developed hepatic encephalopathy (22%) than did those who underwent BRTO (0%, = 0.01). There was no statistically significant difference in mean survival between the two groups (TIPS, 30 months; BRTO, 24 months; = 0.16); median survival for the patients who received TIPS was 16.6 months, and for those who underwent BRTO, it was 26.6 months.

Conclusion: BRTO is an effective method of treating isolated gastric varices with similar outcomes and complication rates to those of TIPS with a covered stent but with a lower rate of hepatic encephalopathy.

Citing Articles

Comparison of the management of gastric variceal bleeding techniques.

Ilyas F, Ali H, Patel P, Shah N, Ishtiaq R, Giammarino A JGH Open. 2024; 7(12):908-915.

PMID: 38162851 PMC: 10757495. DOI: 10.1002/jgh3.13001.


Emergent TIPS for acute gastroesophageal variceal bleeding in cirrhotic patients with hepatocellular carcinoma.

Huang J, Zhong B, Li W, Jiang N, Qian D, Hu Z Abdom Radiol (NY). 2023; 49(3):900-907.

PMID: 38010526 DOI: 10.1007/s00261-023-04088-5.


Use of Balloon Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: A Narrative Review.

Khakwani A, Trivedi M, Afzal M, Kahlon P, Khola , Patel P Cureus. 2023; 15(4):e38233.

PMID: 37257163 PMC: 10225054. DOI: 10.7759/cureus.38233.


Comparison of efficacy and safety of endoscopic and radiological interventions for gastric varices: A systematic review and network meta-analysis.

Giri S, Jearth V, Seth V, Darak H, Sundaram S Clin Exp Hepatol. 2023; 9(1):57-70.

PMID: 37064836 PMC: 10090989. DOI: 10.5114/ceh.2023.126077.


Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices.

Wu Z, Wu W, Tao C, Liu Q, Li W, Wang Q J Interv Med. 2022; 5(3):138-142.

PMID: 36317150 PMC: 9617148. DOI: 10.1016/j.jimed.2022.06.002.


References
1.
Saad W, Kitanosono T, Koizumi J, Hirota S . The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol. 2013; 16(2):101-51. DOI: 10.1053/j.tvir.2013.02.003. View

2.
Fukuda T, Hirota S, Sugimura K . Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001; 12(3):327-36. DOI: 10.1016/s1051-0443(07)61912-5. View

3.
Katoh K, Sone M, Hirose A, Inoue Y, Fujino Y, Onodera M . Balloon-occluded retrograde transvenous obliteration for gastric varices: the relationship between the clinical outcome and gastrorenal shunt occlusion. BMC Med Imaging. 2010; 10:2. PMC: 2820437. DOI: 10.1186/1471-2342-10-2. View

4.
Watanabe M, Shiozawa K, Ikehara T, Nakano S, Kougame M, Otsuka T . Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices. ISRN Gastroenterol. 2013; 2012:919371. PMC: 3523156. DOI: 10.5402/2012/919371. View

5.
Haskal Z, Rees C, Ring E, Saxon R, Sacks D . Reporting standards for transjugular intrahepatic portosystemic shunts. Technology Assessment Committee of the SCVIR. J Vasc Interv Radiol. 1997; 8(2):289-97. DOI: 10.1016/s1051-0443(97)70558-x. View